Bottom line
Is BPIRX a good fund? The bottom line
BPIRX is the Institutional Class share class of Boston Partners Long/Short Research Fund, an actively managed large blend mutual fund from Rbb.
Its expense ratio is 2.09% — about $209 a year on every $10,000 invested, more expensive than 94% of large blend funds we track.
It returned +15.0% over one year, +12.5% a year over five years, +6.6% a year over ten (as of Dec 31, 2025, per its prospectus).
With $588 million in net assets and 422 holdings, its largest position is Flex Ltd (1.9%) and the top 10 make up 12.2% of the portfolio.
What stands out
- 5-year return beat 71% of category peers
- Broadly diversified (422 holdings)
What to watch
- Expensive for its category (2.09%)
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What BPIRX invests in
The Boston Partners Long/Short Research Fund (the Fund) seeks long-term growth of capital with reduced exposure to general equity market risk.
"The Fund uses a hedged strategy. The Fund actively invests in long positions in stocks identified by the Adviser as undervalued and takes short positions in stocks that the Adviser has identified as overvalued. The cash proceeds from short sales (i.e., sales of securities the Fund does not own) are invested in short-term cash instruments to produce a return on such proceeds just below the federal funds rate. Short sales are considered speculative transactions and a form of leverage. The Fund invests, both long and short, in equity securities issued by large-, mid- and small (or ""micro"") cap companies, as well as other instruments that are convertible into equity securities. Selling securities short is a form of leverage. Equity securities in which the Fund may invest include exchange-traded and over-the-counter common and preferred stocks, warrants, rights, convertible securities…
From the fund's prospectus (filed Jul 2, 2026).
BPIRX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| BPIRX | +15.0% | +12.5% | +6.6% |
| Large Blend median | +13.8% | +9.7% | +10.9% |
Source: Fund prospectus, as of Dec 31, 2025
What BPIRX costs
On a $10,000 investment, BPIRX's 2.09% expense ratio costs about $209 a year. The prospectus estimates $21,585 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.
BPIRX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Flex Ltd FLEX | 1.90% |
| 2 | Seagate Technology Holdings PL STX | 1.47% |
| 3 | Frontdoor Inc FTDR | 1.40% |
| 4 | JPMorgan Chase & Co JPM | 1.27% |
| 5 | AbbVie Inc ABBV | 1.09% |
| 6 | Wells Fargo & Co WFC | 1.09% |
| 7 | UnitedHealth Group Inc UNH | 1.03% |
| 8 | Broadcom Inc AVGO | 1.01% |
| 9 | Bank of America Corp BAC | 0.97% |
| 10 | Lam Research Corp LRCX | 0.96% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 12.2% of the fund. See all top 25 holdings and asset mix →